These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 24703854)
21. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation. Machicao VI; Krishna M; Bonatti H; Aqel BA; Nguyen JH; Weigand SD; Rosser BG; Hughes C; Dickson RC Liver Transpl; 2004 May; 10(5):599-606. PubMed ID: 15108251 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Garcia-Retortillo M; Forns X; Llovet JM; Navasa M; Feliu A; Massaguer A; Bruguera M; Fuster J; Garcia-Valdecasas JC; Rimola A Hepatology; 2004 Sep; 40(3):699-707. PubMed ID: 15349910 [TBL] [Abstract][Full Text] [Related]
24. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study. Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436 [TBL] [Abstract][Full Text] [Related]
26. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation. Manousou P; Dhillon AP; Isgro G; Calvaruso V; Luong TV; Tsochatzis E; Xirouchakis E; Kalambokis G; Cross TJ; Rolando N; O'Beirne J; Patch D; Thornburn D; Burroughs AK Liver Transpl; 2011 Feb; 17(2):178-88. PubMed ID: 21280191 [TBL] [Abstract][Full Text] [Related]
27. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C. Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328 [TBL] [Abstract][Full Text] [Related]
28. Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C. Ciccorossi P; Maina AM; Oliveri F; Petruccelli S; Leandro G; Colombatto P; Moriconi F; Mosca F; Filipponi F; Bonino F; Brunetto MR Liver Int; 2007 Jun; 27(5):612-9. PubMed ID: 17498245 [TBL] [Abstract][Full Text] [Related]
29. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138 [TBL] [Abstract][Full Text] [Related]
30. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875 [TBL] [Abstract][Full Text] [Related]
31. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C. Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343 [TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease. Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510 [TBL] [Abstract][Full Text] [Related]
33. Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study). Dumortier J; Salamé E; Roche B; Hurtova M; Conti F; Radenne S; Vanlemmens C; Pageaux GP; Saliba F; Samuel D; Compagnon P; Neau-Cransac M; Calmus Y; Guillaud O; Gugenheim J; Altieri M; Durand F; Hardwigsen J; Lorho R; Dharancy S; Leroy V; Di Giambattista F; Duvoux C Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):292-9. PubMed ID: 24685602 [TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up. Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468 [TBL] [Abstract][Full Text] [Related]
35. Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation. Gambato M; Crespo G; Torres F; LLovet L; Carrión J; Londoño M; Lens S; Mariño Z; Bartres C; Miquel R; Navasa M; Forns X Transpl Int; 2016 Jun; 29(6):698-706. PubMed ID: 26661662 [TBL] [Abstract][Full Text] [Related]
36. Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients. O'Leary JG; Kaneku H; Jennings L; Susskind BM; Terasaki PI; Klintmalm GB Liver Transpl; 2014 Jun; 20(6):655-63. PubMed ID: 24678017 [TBL] [Abstract][Full Text] [Related]